305 related articles for article (PubMed ID: 19339552)
1. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
[TBL] [Abstract][Full Text] [Related]
2. The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling.
Lång E; Grudic A; Pankiv S; Bruserud O; Simonsen A; Bjerkvig R; Bjørås M; Bøe SO
Blood; 2012 Jul; 120(4):847-57. PubMed ID: 22692509
[TBL] [Abstract][Full Text] [Related]
3. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
4. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic PML function in TGF-beta signalling.
Lin HK; Bergmann S; Pandolfi PP
Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
[TBL] [Abstract][Full Text] [Related]
6. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.
Quimby BB; Yong-Gonzalez V; Anan T; Strunnikov AV; Dasso M
Oncogene; 2006 May; 25(21):2999-3005. PubMed ID: 16501610
[TBL] [Abstract][Full Text] [Related]
7. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
8. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
[TBL] [Abstract][Full Text] [Related]
9. Promyelocytic leukemia bodies tether to early endosomes during mitosis.
Palibrk V; Lång E; Lång A; Schink KO; Rowe AD; Bøe SO
Cell Cycle; 2014; 13(11):1749-55. PubMed ID: 24675887
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.
Zhang XW; Yan XJ; Zhou ZR; Yang FF; Wu ZY; Sun HB; Liang WX; Song AX; Lallemand-Breitenbach V; Jeanne M; Zhang QY; Yang HY; Huang QH; Zhou GB; Tong JH; Zhang Y; Wu JH; Hu HY; de Thé H; Chen SJ; Chen Z
Science; 2010 Apr; 328(5975):240-3. PubMed ID: 20378816
[TBL] [Abstract][Full Text] [Related]
12. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
13. Visualization of PML nuclear import complexes reveals FG-repeat nucleoporins at cargo retrieval sites.
Lång A; Eriksson J; Schink KO; Lång E; Blicher P; Połeć A; Brech A; Dalhus B; Bøe SO
Nucleus; 2017 Jul; 8(4):404-420. PubMed ID: 28402725
[TBL] [Abstract][Full Text] [Related]
14. New insights into the cytoplasmic function of PML.
Salomoni P; Bellodi C
Histol Histopathol; 2007 Aug; 22(8):937-46. PubMed ID: 17503350
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic PML: from molecular regulation to biological functions.
Jin G; Gao Y; Lin HK
J Cell Biochem; 2014 May; 115(5):812-8. PubMed ID: 24288198
[TBL] [Abstract][Full Text] [Related]
16. The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia.
Qiu JJ; Chu H; Lu X; Jiang X; Dong S
Oncogene; 2011 Feb; 30(8):967-77. PubMed ID: 20972455
[TBL] [Abstract][Full Text] [Related]
17. Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1.
Dellaire G; Eskiw CH; Dehghani H; Ching RW; Bazett-Jones DP
J Cell Sci; 2006 Mar; 119(Pt 6):1034-42. PubMed ID: 16492707
[TBL] [Abstract][Full Text] [Related]
18. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
19. PML-RARα and its phosphorylation regulate pml oligomerization and HIPK2 stability.
Shima Y; Honma Y; Kitabayashi I
Cancer Res; 2013 Jul; 73(14):4278-88. PubMed ID: 23722549
[TBL] [Abstract][Full Text] [Related]
20. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
Fuchs O; Provazníková D; Peslová G
Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]